Myhre Syndrome Foundation awards $150,000 in grants
Myhre Syndrome Foundation has awarded $150000 in research grants to two awardees that will advance knowledge of Myhre syndrome.
Dr Bert Callewaert, Ghent University, Belgium, will establish a zebrafish model to determine the
disease mechanisms and to test potential therapeutic therapies.
Dr Angela Lin and Dr Mark Lindsay, Massachusetts General Hospital, Boston, will define the cardiovascular phenotype in humans with Myhre syndrome and use a mouse model to examine the features of the cardiovascular manifestations to improve treatment and aid prevention.
Both proposals were commended on the potential impact to advance knowledge and treatment options for Myhre and provide longer-term opportunities for development. The proposals also align with the priorities that the Myhre community identified.
Kathy Young, Myhre Syndrome Foundation vice-president and scientific committee leader said, “We are delighted to award grants to two well-established research institutions; this funding will move forward knowledge on incredibly important areas for Myhre syndrome. We are so grateful to everyone who supports the foundation, as you made this possible.”
About Myhre Syndrome Foundation
The Myhre Syndrome Foundation is a patient advocacy organisation dedicated to providing hope and improving the lives of those impacted by Myhre Syndrome.
We foster collaboration among all relevant stakeholders to build a strong, global community, in order to advance research, support, education and advocacy for those impacted by Myhre Syndrome.
Myhre syndrome is an ultra-rare disorder, with only around 200 cases in the world. Affected individuals often have problems with the cardiovascular and respiratory systems. Some of these problems gradually get worse and can lead to potentially life-threatening complications. Currently there is no cure.
Find out more at www.myhresyndrome.org